Clinical Indication

Type 2 Diabetes


If prescriber has not received specific training.
To be used in line with NICE Guidelines CG66
Once a week preparation (Bydureon®) is formulary.
Twice daily preparation (Byetta®) is non-formulary. However, existing patients may remain on treatment.

Date of classification

December 2010


Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .